{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:26:54Z","timestamp":1787023614456,"version":"build-2736575974"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,12,15]]},"DOI":"10.18632\/aging.205304","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T09:01:25Z","timestamp":1702458085000},"page":"14306-14322","source":"Crossref","is-referenced-by-count":4,"title":["DOK7, a target of miR-299-5p, suppresses the progression of bladder cancer"],"prefix":"10.18632","volume":"15","author":[{"given":"Xuemei","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Anesthesia Surgery Center, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesia Surgery Center, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"He","sequence":"additional","affiliation":[{"name":"Department of Urology, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Urology, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020.","volume":"7","author":"Galsky","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"2","first-page":"507","article-title":"Bladder Cancer: Diagnosis and Treatment.","volume":"9","author":"Hodges","year":"2017","journal-title":"Am Fam Physician"},{"key":"3","doi-asserted-by":"publisher","first-page":"890172","DOI":"10.3389\/fsurg.2022.890172","article-title":"Editorial: Recent Advances in Bladder Cancer Diagnosis and Treatment.","volume":"9","author":"Castellani","year":"2022","journal-title":"Front Surg"},{"key":"4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ijrobp.2015.08.023","article-title":"Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial.","volume":"9","author":"Creutzberg","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.3390\/cancers13092214","article-title":"Nanotechnology in Bladder Cancer: Diagnosis and Treatment.","volume":"1","author":"Pandey","year":"2021","journal-title":"Cancers (Basel)"},{"key":"6","doi-asserted-by":"publisher","first-page":"e16363","DOI":"10.5812\/numonthly.16363","article-title":"Novel optical technology in bladder cancer diagnosis and treatment.","volume":"6","author":"Papatsoris","year":"2014","journal-title":"Nephrourol Mon"},{"key":"7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/ncpuro0318","article-title":"Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.","volume":"2","author":"Jones","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"8","doi-asserted-by":"publisher","first-page":"738364","DOI":"10.3389\/fcell.2021.738364","article-title":"ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K\/AKT Signaling Pathway.","volume":"9","author":"Luo","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"9","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3892\/ol.2018.9845","article-title":"Lost expression of cell adhesion molecule 1 is associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors.","volume":"1","author":"Liu","year":"2019","journal-title":"Oncol Lett"},{"key":"10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1053\/j.seminoncol.2006.12.013","article-title":"Molecular alterations associated with bladder cancer progression.","volume":"3","author":"Cordon-Card\u00f3","year":"2007","journal-title":"Semin Oncol"},{"key":"11","doi-asserted-by":"publisher","first-page":"dmm047662","DOI":"10.1242\/dmm.047662","article-title":"miRNA interplay: mechanisms and consequences in cancer.","volume":"1","author":"Tran","year":"2021","journal-title":"Dis Model Mech"},{"key":"12","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3390\/genes12081289","article-title":"MiRNAs and Cancer: Key Link in Diagnosis and Therapy.","volume":"1","author":"Gong","year":"2021","journal-title":"Genes (Basel)"},{"key":"13","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","article-title":"OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.","volume":"7","author":"Slack","year":"2016","journal-title":"Cancer Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2490-14-50","article-title":"microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer.","volume":"1","author":"Yu","year":"2014","journal-title":"BMC Urol"},{"key":"15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/or.2018.6879","article-title":"MicroRNA-154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7.","volume":"4","author":"Yao","year":"2019","journal-title":"Oncol Rep"},{"key":"16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12935-015-0235-8","article-title":"Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer.","volume":"1","author":"Gu","year":"2015","journal-title":"Cancer Cell Int"},{"key":"17","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1126\/science.1127142","article-title":"The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.","volume":"31","author":"Yamanashi","year":"2006","journal-title":"Science"},{"key":"18","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1093\/hmg\/dds198","article-title":"The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.","volume":"2","author":"Beeson","year":"2012","journal-title":"Hum Mol Genet"},{"key":"19","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.biopha.2018.06.156","article-title":"Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation.","volume":"10","author":"Zhao","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"20","doi-asserted-by":"publisher","first-page":"4035257","DOI":"10.1155\/2021\/4035257","article-title":"DOK7 Inhibits Cell Proliferation, Migration, and Invasion of Breast Cancer via the PI3K\/PTEN\/AKT Pathway.","volume":"202","author":"Liu","year":"2021","journal-title":"J Oncol"},{"key":"21","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3390\/cancers11122002","article-title":"JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression.","volume":"1","author":"Parker","year":"2019","journal-title":"Cancers (Basel)"},{"key":"22","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/cancers12071971","article-title":"JAK-STAT Signalling Pathway in Cancer.","volume":"1","author":"Putoczki","year":"2020","journal-title":"Cancers (Basel)"},{"key":"23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fmolb.2020.00218","article-title":"RAC3 Promotes Proliferation, Migration and Invasion via PYCR1\/JAK\/STAT Signaling in Bladder Cancer.","volume":"7","author":"Liu","year":"2020","journal-title":"Front Mol Biosci"},{"key":"24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3892\/ol.2021.12997","article-title":"ST8SIA1 inhibits the proliferation, migration and invasion of bladder cancer cells by blocking the JAK\/STAT signaling pathway.","volume":"2","author":"Jiang","year":"2021","journal-title":"Oncol Lett"},{"key":"25","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/ijms21031106","article-title":"STAT3\/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy.","volume":"2","author":"Nawroth","year":"2020","journal-title":"Int J Mol Sci"},{"key":"26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.20524\/aog.2017.0139","article-title":"Importance of miR-299-5p in colorectal cancer.","volume":"3","author":"Azarbarzin","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.bulcan.2018.07.013","article-title":"Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1.","volume":"10","author":"Shen","year":"2018","journal-title":"Bull Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"10","author":"Mesirov","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29","doi-asserted-by":"publisher","first-page":"51046","DOI":"10.3791\/51046","article-title":"In vitro cell migration and invasion assays.","author":"Yang","year":"2014","journal-title":"J Vis Exp"},{"key":"30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3892\/ijo.2018.4624","article-title":"DOK7V1 influences the malignant phenotype of lung cancer cells through PI3K\/AKT\/mTOR and FAK\/paxillin signaling pathways.","volume":"5","author":"Jiang","year":"2019","journal-title":"Int J Oncol"},{"key":"31","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.4014\/jmb.2106.06031","article-title":"Hsa_Circ_0001947\/MiR-661\/DOK7 Axis Restrains Non-Small Cell Lung Cancer Development.","volume":"3","author":"Zhang","year":"2021","journal-title":"J Microbiol Biotechnol"},{"key":"32","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.3892\/or.2017.5538","article-title":"The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer.","volume":"3","author":"Jiang","year":"2017","journal-title":"Oncol Rep"},{"key":"33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.4103\/ijc.IJC_100_18","article-title":"Examination of methylation changes of VIM, CXCR4, DOK7, and SPDEF genes in peripheral blood DNA in breast cancer patients.","volume":"5","author":"Aleyasin","year":"2018","journal-title":"Indian J Cancer"},{"key":"34","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3892\/ol.2016.4621","article-title":"miR-299-5p promotes cell growth and regulates G1\/S transition by targeting p21Cip1\/Waf1 in acute promyelocytic leukemia.","volume":"1","author":"Zhan","year":"2016","journal-title":"Oncol Lett"},{"key":"35","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.26355\/eurrev_201805_14954","article-title":"MiR-299-5p targets cell cycle to promote cell proliferation and progression of osteosarcoma.","volume":"2","author":"Dong","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"36","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3892\/or.2020.7486","article-title":"MicroRNA-299-5p inhibits cell metastasis in breast cancer by directly targeting serine\/threonine kinase 39.","volume":"4","author":"Zhou","year":"2020","journal-title":"Oncol Rep"},{"key":"37","doi-asserted-by":"publisher","first-page":"821344","DOI":"10.3389\/fphar.2022.821344","article-title":"JAK\/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies.","volume":"1","author":"Bhat","year":"2022","journal-title":"Front Pharmacol"},{"key":"38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fendo.2020.00033","article-title":"Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise.","volume":"1","author":"Fragala","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"39","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1002\/ijc.30666","article-title":"Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.","volume":"14","author":"Yamasaki","year":"2017","journal-title":"Int J Cancer"},{"key":"40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12964-020-0527-z","article-title":"Role of STAT3 signaling pathway in breast cancer.","volume":"1","author":"Li","year":"2020","journal-title":"Cell Commun Signal"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T11:20:49Z","timestamp":1703071249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":40,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,12,15]]}},"alternative-id":["205304","38095644"],"URL":"https:\/\/doi.org\/10.18632\/aging.205304","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]}}}